[Abstract Only] Randomized Trial: First-Line Therapies for Metastatic Prostate Cancer Compared
30 Jun, 2019 | 17:16h | UTCEnzalutamide with Standard First-Line Therapy in Metastatic Prostate Cancer – New England Journal of Medicine (link to abstract – $ for full-text)
Commentary: ENZAMET Trial Shows Enzalutamide Improves Overall Survival in Hormone-Sensitive Metastatic Prostate Cancer – The ASCO Post (free)